NIH-funded research R01 grant

Inherited DNA patterns linked to Alzheimer's and brain scans

Official title: Efficient IBD mapping for Alzheimer's Disease and related brain imaging phenotypes

Funded at New York University · NIH-11502896 · Data updated 2026-11-12

Researchers will look for shared inherited DNA segments to find genetic factors linked to Alzheimer's disease and related brain-imaging changes in people.

More Alzheimer's Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$339,495
NIH project number7R01AG081398-03
Project IDNIH-11502896 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer's, those with a family history of the disease, or volunteers willing to share genetic data and brain scans through biobanks would be most relevant to this research.

Less likely to help

Patients looking for immediate new therapies or symptom relief should not expect direct benefit because this is genetic mapping research rather than a treatment trial.

What this research studies

This project uses large genetic and brain-imaging datasets to search for stretches of DNA that relatives share (identical-by-descent) that may carry Alzheimer's risk. The team will build faster statistical and computational tools to find these shared segments in very large samples. They will apply these tools to UK Biobank brain-imaging data and try to replicate findings in the Alzheimer’s Disease Sequencing Project, combining evidence across diverse populations. The researchers plan to share their methods and results publicly so other scientists and clinicians can use them.

Why it matters

Potential benefit: If successful, the work could reveal new genetic regions tied to Alzheimer's that improve risk prediction and point to targets for future treatment research.

How similar studies have gone: Previous genome-wide studies have identified some Alzheimer's risk genes, but using identical-by-descent mapping on large imaging datasets is a newer and less-tested approach.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Chen, Han — New York University
  • Study coordinator: Chen, Han

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.